Subdural Hematoma and Oral Anticoagulation: A Therapeutic Dilemma from the Neurosurgical Point of View

Journal of Neurological Surgery, Part A: Central European Neurosurgery

Volumn 77, Issue 1, 2015, Pages 31-35

  Mirzayan, M Javad ^a   Calvelli, Karoline ^a   Capelle, Hans Holger ^a   Weigand, Jessica ^a   Krauss, Joachim K ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

oral anticoagulation; phenprocoumon; subdural hematoma; thrombosis; warfarin

Indexed keywords

PHENPROCOUMON; ANTICOAGULANT AGENT; WARFARIN;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLEEDING; CLINICAL ARTICLE; CLINICAL DECISION MAKING; DRUG WITHDRAWAL; EVENT FREE SURVIVAL; FEMALE; HUMAN; MALE; MORTALITY; NEUROSURGERY; RETROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; SUBDURAL HEMATOMA; THROMBOEMBOLISM; TREATMENT OUTCOME; CHEMICALLY INDUCED; DISEASE FREE SURVIVAL; FOLLOW UP; HEMATOMA, SUBDURAL; KAPLAN MEIER METHOD; MIDDLE AGED; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMATOMA, SUBDURAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHENPROCOUMON; RETROSPECTIVE STUDIES; THROMBOEMBOLISM; TREATMENT OUTCOME; WARFARIN;

EID: 84954398585     PISSN: 21936315     EISSN: 21936323     Source Type: Journal    
DOI: 10.1055/s-0035-1558407     Document Type: Article

References (46)

1. Taborski U., Müller-Berghaus G. State-of-the-art patient self-management for control of oral anticoagulation. Semin Thromb Hemost: 1999; 25 1 43 47
2. Connolly B. J., Pearce L. A., Hart R. G. Vitamin K antagonists and risk of subdural hematoma: meta-analysis of randomized clinical trials. Stroke: 2014; 45 6 1672 1678
3. Hylek E. M. Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors. Semin Vasc Med: 2003; 3 3 271 278
4. Hart R. G., Boop B. S., Anderson D. C. Oral anticoagulants and intracranial hemorrhage. Facts and hypotheses. Stroke: 1995; 26 8 1471 1477
5. Bertram M., Bonsanto M., Hacke W., Schwab S. Managing the therapeutic dilemma: patients with spontaneous intracerebral hemorrhage and urgent need for anticoagulation. J Neurol: 2000; 247 3 209 214
6. Qureshi A. I., Tuhrim S., Broderick J. P., Batjer H. H., Hondo H., Hanley D. F. Spontaneous intracerebral hemorrhage. N Engl J Med: 2001; 344 19 1450 1460
7. Claassen D. O., Kazemi N., Zubkov A. Y., Wijdicks E. F., Rabinstein A. A. Restarting anticoagulation therapy after warfarin-associated intracerebral hemorrhage. Arch Neurol: 2008; 65 10 1313 1318
8. Mattle H., Kohler S., Huber P., Rohner M., Steinsiepe K. F. Anticoagulation-related intracranial extracerebral haemorrhage. J Neurol Neurosurg Psychiatry: 1989; 52 7 829 837
9. Rust T., Kiemer N., Erasmus A. Chronic subdural haematomas and anticoagulation or anti-thrombotic therapy. J Clin Neurosci: 2006; 13 8 823 827
10. Duff I. F., Shull W. H. Fatal hemorrhage in dicumarol poisoning; with report of necropsy. J Am Med Assoc: 1949; 139 12 762 766
11. Palareti G., Leali N., Coccheri S., et al. Italian Study on Complications of Oral Anticoagulant Therapy. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet: 1996; 348 9025 423 428
12. Beyth R. J., Quinn L. M., Landefeld C. S. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med: 1998; 105 2 91 99
13. Van Der Veken J., Duerinck J., Buyl R., Van Rompaey K., Herregodts P., D'Haens J. Mini-craniotomy as the primary surgical intervention for the treatment of chronic subdural hematoma--a retrospective analysis. Acta Neurochir (Wien): 2014; 156 5 981 987
14. Forster M. T., Mathé A. K., Senft C., Scharrer I., Seifert V., Gerlach R. The influence of preoperative anticoagulation on outcome and quality of life after surgical treatment of chronic subdural hematoma. J Clin Neurosci: 2010; 17 8 975 979
15. Snyder M., Renaudin J. Intracranial hemorrhage associated with anticoagulation therapy. Surg Neurol: 1977; 7 1 31 34
16. Rosand J., Eckman M. H., Knudsen K. A., Singer D. E., Greenberg S. M. The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med: 2004; 164 8 880 884
17. Jeffree R. L., Gordon D. H., Sivasubramaniam R., Chapman A. Warfarin related intracranial haemorrhage: a case-controlled study of anticoagulation monitoring prior to spontaneous subdural or intracerebral haemorrhage. J Clin Neurosci: 2009; 16 7 882 885
18. Gallus A. S., Baker R. I., Chong B. H., Ockelford P. A., Street A. M. Consensus guidelines for warfarin therapy. Recommendations from the Australasian Society of Thrombosis and Haemostasis. Med J Aust: 2000; 172 12 600 605
19. Wintzen A. R., Tijssen J. G. Subdural hematoma and oral anticoagulant therapy. Arch Neurol: 1982; 39 2 69 72
20. Rizos T., Jenetzky E., Herweh C., Unterberg A., Hacke W., Veltkamp R. Fast point-of-care coagulometer guided reversal of oral anticoagulation at the bedside hastens management of acute subdural hemorrhage. Neurocrit Care: 2010; 13 3 321 325
21. Moskopp D., Brassel F., Ries F. Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986. [in German]. Klin Wochenschr: 1987; 65 16 781 790
22. Senft C., Schuster T., Forster M. T., Seifert V., Gerlach R. Management and outcome of patients with acute traumatic subdural hematomas and pre-injury oral anticoagulation therapy. Neurol Res: 2009; 31 10 1012 1018
23. Weigel R., Schmiedek P., Krauss J. K. Outcome of contemporary surgery for chronic subdural haematoma: evidence based review. J Neurol Neurosurg Psychiatry: 2003; 74 7 937 943
24. König S. A., Schick U., Döhnert J., Goldammer A., Vitzthum H. E. Coagulopathy and outcome in patients with chronic subdural haematoma. Acta Neurol Scand: 2003; 107 2 110 116
25. Quon J. A., Thiel H. W., Cassidy J. D., Donat J. R. Anticoagulant therapy and subdural hematoma formation. J Manipulative Physiol Ther: 1990; 13 1 30 32
26. Hirsh J., Fuster V.; American Heart Association. Guide to anticoagulant therapy. Part 2: Oral anticoagulants. Circulation: 1994; 89 3 1469 1480
27. Diamond T., Gray W. J., Chee C. P., Fannin T. F. Subdural haematoma associated with long term oral anticoagulation. Br J Neurosurg: 1988; 2 3 351 355
28. Fihn S. D., McDonell M., Martin D., et al. Warfarin Optimized Outpatient Follow-up Study Group. Risk factors for complications of chronic anticoagulation. A multicenter study. Ann Intern Med: 1993; 118 7 511 520
29. Franke C. L., de Jonge J., van Swieten J. C., Op de Coul A. A., van Gijn J. Intracerebral hematomas during anticoagulant treatment. Stroke: 1990; 21 5 726 730
30. Phan T. G., Koh M., Wijdicks E. F. Safety of discontinuation of anticoagulation in patients with intracranial hemorrhage at high thromboembolic risk. Arch Neurol: 2000; 57 12 1710 1713
31. Gorter J. W. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups. Neurology: 1999; 53 6 1319 1327
32. Butchart E. G., Gohlke-Bärwolf C., Antunes M. J., et al. Working Groups on Valvular Heart Disease, Thrombosis, and Cardiac Rehabilitation and Exercise Physiology, European Society of Cardiology. Recommendations for the management of patients after heart valve surgery. Eur Heart J: 2005; 26 22 2463 2471
33. Amin A. G., Ng J., Hsu W., et al. Postoperative anticoagulation in patients with mechanical heart valves following surgical treatment of subdural hematomas. Neurocrit Care: 2013; 19 1 90 94
34. Cannegieter S. C., Rosendaal F. R., Wintzen A. R., van der Meer F. J., Vandenbroucke J. P., Briët E. Optimal oral anticoagulant therapy in patients with mechanical heart valves. N Engl J Med: 1995; 333 1 11 17
35. Chari A., Clemente Morgado T., Rigamonti D. Recommencement of anticoagulation in chronic subdural haematoma: a systematic review and meta-analysis. Br J Neurosurg: 2014; 28 1 2 7
36. Romualdi E., Micieli E., Ageno W., Squizzato A. Oral anticoagulant therapy in patients with mechanical heart valve and intracranial haemorrhage. A systematic review. Thromb Haemost: 2009; 101 2 290 297
37. Yeon J. Y., Kong D. S., Hong S. C. Safety of early warfarin resumption following burr hole drainage for warfarin-associated subacute or chronic subdural hemorrhage. J Neurotrauma: 2012; 29 7 1334 1341
38. Kawamata T., Takeshita M., Kubo O., Izawa M., Kagawa M., Takakura K. Management of intracranial hemorrhage associated with anticoagulant therapy. Surg Neurol: 1995; 44 5 438 442; discussion 443
39. Aspegren O. P., Åstrand R., Lundgren M. I., Romner B. Anticoagulation therapy a risk factor for the development of chronic subdural hematoma. Clin Neurol Neurosurg: 2013; 115 7 981 984
40. El Ahmadieh T. Y., Aoun S. G., Daou M. R., et al. New-generation oral anticoagulants for the prevention of stroke: implications for neurosurgery. J Clin Neurosci: 2013; 20 10 1350 1356
41. Le Roux P., Pollack C. V. Jr, Milan M., Schaefer A. Race against the clock: overcoming challenges in the management of anticoagulant-associated intracerebral hemorrhage. J Neurosurg: 2014; 121 (Suppl): 1 20
42. Broderick J. P., Adams H. P. Jr, Barsan W., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke: 1999; 30 4 905 915
43. Appelboam R., Thomas E. O. Warfarin and intracranial haemorrhage. Blood Rev: 2009; 23 1 1 9
44. Thrift A. G., McNeil J. J., Forbes A., Donnan G. A.; Melbourne Risk Factor Study Group. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Hypertension: 1998; 31 6 1223 1229
45. Fountain R. B., Holmes D. R., Chandrasekaran K., et al. The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial. Am Heart J: 2006; 151 5 956 961
46. Holmes D. R., Reddy V. Y., Turi Z. G., et al. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomized non-inferiority trial. Lancet: 2009; 374 9689 532 542